Skip to content
ProPublica Donate
ProPublica Donate

Baptist Clinical Research Institute Inc

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Science and Technology Research Institutes, Services / Research Institutes and/or Public Policy Analysis (NTEE)

Donations to this organization are tax deductible.

Summary charts: organization finances over time

Revenue
$2.16M (2023)

Expenses
$4.26M (2023)

Total Assets
$456k (2023)

Total Liabilities
$15.7M (2023)

Source: Form 990 tax filings from 2013 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Sept.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,161,067
Expenses
$4,263,925
Net Income
-$2,102,858
Net Assets
-$15,251,311
Notable Sources of Revenue Percent of Total Revenue
Contributions $375,696
17.4%
Program Services $1,785,371
82.6%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $223,350
5.2%
Professional Fundraising Fees $0
Other Salaries and Wages $2,877,055
67.5%
Assets/Debt
Total Assets $455,611
Total Liabilities $15,706,922
Net Assets -$15,251,311
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director Dev Res (Thru 01/23)) $236,687 $0 $34,424
Huibo Shao (Scientist Research Iii) $120,856 $0 $79
Glenn Roma (Pharmacist Investigational) $115,783 $0 $33,431
Tracy B Stewart (Assistant Director Research) $115,249 $0 $32,072
Paul Koros (Director Clinical Research) $114,956 $0 $36,629
Alexander R Quesenberry (Dir. Pharm. Infusion Center/Research) $86,297 $85,663 $58,499
Paul D Depriest Md (President/Director (Thru 08/23)) $0 $1,407,602 $87,814
William A Griffin (Director) $0 $1,190,725 $67,371
Gregory M Duckett (Secretary/Director) $0 $1,120,752 $82,097
Gary C Anderson (President/Director (As Of 09/23)) $0 $1,062,887 $83,871
Philip Lammers Md (Director) $0 $1,014,084 $54,838
Mark E Swanson Md (Director) $0 $1,000,668 $21,797
Ropo O Sanvee (Cfo) $0 $114,250 $32,135
Kimberly O Young (Former Cfo) $0 $470,223 $44,046

Document Links

Fiscal Year Ending Sept.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$1,800,525
Expenses
$4,347,213
Net Income
-$2,546,688
Net Assets
-$13,148,453
Notable Sources of Revenue Percent of Total Revenue
Contributions $219,581
12.2%
Program Services $1,580,944
87.8%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $269,027
6.2%
Professional Fundraising Fees $0
Other Salaries and Wages $2,877,249
66.2%
Assets/Debt
Total Assets $507,696
Total Liabilities $13,656,149
Net Assets -$13,148,453
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director Dev Res) $230,497 $0 $33,205
Glenn Roma (Pharmacist Investigational) $128,288 $0 $15,989
Huibo Shao (Scientist Research Iii) $117,022 $0 $6,960
Paul Koros (Director Clinical Research) $114,721 $0 $29,488
Hannah K Alley (Compliance Research Senior) $105,227 $0 $30,614
Alexander R Quesenberry (Dir. Pharm. Infusion Center/Research) $88,974 $81,560 $53,078
William A Griffin (Director) $0 $1,517,815 $64,834
Mark E Swanson Md (Director) $0 $1,355,514 $22,684
Philip Lammers Md (Director) $0 $850,104 $51,904
Paul D Depriest Md (President/Director) $0 $2,006,787 $84,638
Gregory M Duckett (Secretary/Director) $0 $1,562,524 $80,090
Ropo O Sanvee (Cfo) $0 $109,561 $30,517
Kimberly O Young (Former Cfo) $0 $523,174 $20,537

Document Links

Fiscal Year Ending Sept.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$1,977,517
Expenses
$3,957,317
Net Income
-$1,979,800
Net Assets
-$10,601,765
Notable Sources of Revenue Percent of Total Revenue
Contributions $146,162
7.4%
Program Services $1,831,355
92.6%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $263,115
6.6%
Professional Fundraising Fees $0
Other Salaries and Wages $2,496,860
63.1%
Assets/Debt
Total Assets $153,363
Total Liabilities $10,755,128
Net Assets -$10,601,765
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director Dev Res) $233,504 $0 $33,630
Glenn Roma (Pharmacist Investigational) $122,456 $0 $13,977
Liset Taybo (Clinical Research Oncology) $113,617 $0 $24,569
Paul Koros (Director Clinical Research) $109,835 $0 $23,616
Alexander R Quesenberry (Pharm. Infusion Cntr/Research) $86,905 $86,510 $47,835
Ropo O Sanvee (Cfo) $59,735 $57,373 $28,865
Paul D Depriest Md (President/Director) $0 $1,820,358 $85,705
Gregory M Duckett (Secretary/Director) $0 $1,370,691 $78,242
William A Griffin (Director) $0 $1,282,673 $63,926
Mark E Swanson Md (Director) $0 $1,219,017 $25,044
Philip Lammers Md (Director (As Of 01/21)) $0 $630,639 $48,287
Kimberly O Young (Former Cfo) $0 $374,634 $33,166

Document Links

Fiscal Year Ending Sept.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$1,729,642
Expenses
$3,213,146
Net Income
-$1,483,504
Net Assets
-$8,621,965
Notable Sources of Revenue Percent of Total Revenue
Contributions $104,560
6.0%
Program Services $1,625,082
94.0%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $255,593
8.0%
Professional Fundraising Fees $0
Other Salaries and Wages $2,104,963
65.5%
Assets/Debt
Total Assets $138,519
Total Liabilities $8,760,484
Net Assets -$8,621,965
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director Dev Res) $220,483 $0 $29,966
Alexander R Quesenberry (Pharm. Infusion Cntr/Research) $160,908 $0 $44,235
Liset Taybo (Clinical Research Oncology) $160,742 $0 $34,747
Glenn Roma (Pharmacist Investigational) $119,415 $0 $15,747
Ropo O Sanvee (Cfo (As Of 06/20)) $108,661 $0 $27,319
Paul D Depriest Md (President/Director) $0 $1,265,263 $66,047
Mark E Swanson Md (Director) $0 $1,179,998 $19,113
William A Griffin (Director) $0 $834,254 $62,248
Gregory M Duckett (Secretary/Director) $0 $728,739 $69,972
Kimberly O Young (Cfo (Thru 05/20)) $0 $224,817 $26,435

Document Links

Fiscal Year Ending Sept.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$2,016,558
Expenses
$3,490,797
Net Income
-$1,474,239
Net Assets
-$7,138,461
Notable Sources of Revenue Percent of Total Revenue
Contributions $575,769
28.6%
Program Services $1,440,789
71.4%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $249,096
7.1%
Professional Fundraising Fees $0
Other Salaries and Wages $2,272,468
65.1%
Assets/Debt
Total Assets $130,843
Total Liabilities $7,269,304
Net Assets -$7,138,461
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director Dev Res) $220,040 $0 $24,874
Liset Taybo (Clinical Research Oncology) $153,516 $0 $16,437
Glenn Roma (Pharmacist Investigational) $106,735 $2,533 $11,295
Ropo O Sanvee (Assistant Director Operations) $101,343 $0 $25,999
Alexander Quesenberry (Pharm. Infusion Cntr/Research) $75,811 $74,427 $38,560
Gregory M Duckett (Secretary/Director) $0 $576,210 $74,991
Mark E Swanson Md (Director) $0 $725,046 $18,635
Paul D Depriest Md (President/Director) $0 $955,671 $64,212
William A Griffin (Director) $0 $635,654 $66,237
Kimberly O Young (Cfo) $0 $239,516 $25,589

Document Links

Fiscal Year Ending Sept.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$1,194,241
Expenses
$2,996,206
Net Income
-$1,801,965
Net Assets
-$5,664,222
Notable Sources of Revenue Percent of Total Revenue
Contributions $94,173
7.9%
Program Services $1,100,068
92.1%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $243,827
8.1%
Professional Fundraising Fees $0
Other Salaries and Wages $1,985,506
66.3%
Assets/Debt
Total Assets $241,554
Total Liabilities $5,905,776
Net Assets -$5,664,222
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec Director Dev Res) $220,070 $0 $22,062
Ropo O Sanvee (Sr. Mgr Clinical Trials) $100,176 $0 $25,018
Gregory M Duckett (Secretary/Director) $0 $643,651 $72,500
Mark E Swanson Md (Director) $0 $789,953 $24,994
Paul D Depriest Md (President/Director) $0 $972,083 $58,146
William A Griffin (Director) $0 $657,593 $67,261
Kimberly O Young (Cfo) $0 $237,591 $24,769

Document Links

Fiscal Year Ending Sept.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$1,508,032
Expenses
$2,890,290
Net Income
-$1,382,258
Net Assets
-$3,862,257
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $1,510,286
> 100%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets -$2,254
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $237,152
8.2%
Professional Fundraising Fees $0
Other Salaries and Wages $1,729,863
59.9%
Assets/Debt
Total Assets $348,638
Total Liabilities $4,210,895
Net Assets -$3,862,257
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director) $209,842 $0 $9,231
Silva H Hanissian (Pharmacist) $102,843 $0 $26,790
Gregory M Duckett (Secretary/Director) $0 $707,234 $63,288
Paul D Depriest Md (Pres./Director) $0 $997,354 $57,787
William A Griffin (Director) $0 $633,939 $56,603
Mark E Swanson Md (Director) $0 $857,430 $24,846

Document Links

Fiscal Year Ending Sept.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$550,645
Expenses
$1,253,149
Net Income
-$702,504
Net Assets
-$2,479,999
Notable Sources of Revenue Percent of Total Revenue
Contributions $24,005
4.4%
Program Services $526,640
95.6%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $225,420
18.0%
Professional Fundraising Fees $0
Other Salaries and Wages $702,010
56.0%
Assets/Debt
Total Assets $225,389
Total Liabilities $2,705,388
Net Assets -$2,479,999
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director) $203,868 $0 $7,546
Gregory M Duckett (Secretary/Director) $0 $635,401 $59,461
Paul D Depriest Md (Pres./Director (Thru 9/16)) $0 $899,879 $55,805
Donald R Pounds (Director (Thru 12/15)) $0 $1,108,342 $79,644
Jason M Little (Pres./Director (Thru 12/15)) $0 $1,245,920 $55,034
William A Griffin (Director (1/16 9/16)) $0 $435,857 $54,076
Mark E Swanson Md (Director) $0 $560,390 $39,155

Document Links

Fiscal Year Ending Sept.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$501,326
Expenses
$882,256
Net Income
-$380,930
Net Assets
-$1,777,495
Notable Sources of Revenue Percent of Total Revenue
Contributions $88,490
17.7%
Program Services $412,836
82.3%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $209,756
23.8%
Professional Fundraising Fees $0
Other Salaries and Wages $445,571
50.5%
Assets/Debt
Total Assets $82,314
Total Liabilities $1,859,809
Net Assets -$1,777,495
Compensation
Key Employees and Officers Compensation Related Other
Margaret Debon (Exec. Director) $167,617 $0 $6,215
Silva H Hanissian (Pharmacist) $8,114 $99,949 $20,380
Paul D Depriest Md (V.P./Director) $0 $872,409 $54,444
Donald R Pounds (Director) $0 $872,409 $54,444
Jason M Little (Pres./Director) $0 $1,012,007 $54,865
Gregory M Duckett (Secretary) $0 $750,243 $58,842

Document Links

Fiscal Year Ending Sept.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$432,289
Expenses
$639,215
Net Income
-$206,926
Net Assets
-$1,396,565
Notable Sources of Revenue Percent of Total Revenue
Contributions $28,243
6.5%
Program Services $404,046
93.5%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $118,444
18.5%
Professional Fundraising Fees $0
Other Salaries and Wages $337,148
52.7%
Assets/Debt
Total Assets $9,717
Total Liabilities $1,406,282
Net Assets -$1,396,565

Document Links

Fiscal Year Ending Sept.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$175,434
Expenses
$725,514
Net Income
-$550,080
Net Assets
-$1,189,639
Notable Sources of Revenue Percent of Total Revenue
Contributions $0
Program Services $175,434
100%
Investment Income $0
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $0
Professional Fundraising Fees $0
Other Salaries and Wages $569,538
78.5%
Assets/Debt
Total Assets $10,667
Total Liabilities $1,200,306
Net Assets -$1,189,639

No Document Links

The IRS has provided extracted financial data for this filing, but has not yet released the source documents.

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »